Fixed Low-dose Simethicone Combined With Macrogol 4000 (PEG) Reduces Colon Bubble Formation in Colonoscopy
Conditions: Colorectal Cancer; Colonoscopy; Bowel Preparation Solution Interventions: Drug: Simethicone combined with Macrogol 4000 (PEG) Sponsors: Hospital St. Joseph, Marseille, France Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Conditions: Platinum-resistant Ovarian Cancer; Recurrent Ovary Cancer; Ovarian Cancer; Ovarian Carcinoma; Ovarian Carcinoma, Recurrent Interventions: Biological: Cytokine-Induced Memory-like Natural Killer Cells; Biological: IL-15 Superagonist Sponsors: Dana-Farber Cancer Institute; ImmunityBio, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the Bone
Conditions: Castration-resistant Prostate Cancer Interventions: Procedure: Imaging evaluation Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs
Conditions: Lung Cancer; Blood Biomarkers Interventions: Diagnostic Test: Artificial Intelligence risk model Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University of Milano Bicocca Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Conditions: Oral Squamous Cell Carcinoma; Oral Potentially Malignant Disorder; Oral Leukoplakia; Proliferative Verrucous Leukoplakia; Oral Lichen Planus; Oral Lichenoid Lesion; Graft-versus-host-disease; Oral Erythroplakia; Actinic Keratoses; Actinic Cheilitis; Oral Cancer; Oral Disease Interventions: Device: OCT (Optical Coherence Tomography) Sponsors: University of Palermo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer
Conditions: Colon Cancer Interventions: Drug: Doublet or triplet chemotherapy combined with cetuximab Sponsors: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes
Conditions: Arm Lymphedema; Breast Cancer; Radiotherapy Side Effect Interventions: Radiation: Hypofractionated radiotherapy scheme Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
Conditions: Advanced Malignant Solid Neoplasm; Metastatic Malignant Solid Neoplasm; Recurrent Malignant Solid Neoplasm; Refractory Malignant Solid Neoplasm Interventions: Biological: Axatilimab; Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: Paclitaxel; Procedure: Positron Emission Tomography; Biological: Retifanlimab Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University; Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Cancer Related Major Depression Treated With a Single Dose of Psilocybin
Conditions: MDD Interventions: Drug: psilocybin 25 mg sod; Drug: psilocybin 1 mg sod Sponsors: Section for Affective Disorders; Northern Stockholm Psychiatry; Uppsala University Hospital; Region Örebro County; Vastra Gotaland Region; Karolinska Institutet Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression
Conditions: Ovarian Cancer Sponsors: Ain Shams University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer
Conditions: Squamous Cell Non-small Cell Lung Cancer Interventions: Drug: JMT101; Drug: docetaxel; Drug: HB1801 Sponsors: Shanghai JMT-Bio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Conditions: HPV-Related Cervical Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma Interventions: Drug: Two IM injections Lenti-HPV-07; Drug: One IM injection Lenti-HPV-07 Sponsors: Theravectys S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone
Conditions: Metastatic Breast Cancer Interventions: Other: WB-MRI Sponsors: European Institute of Oncology Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma; Herpesvirus 4, Human Interventions: Diagnostic Test: EBV-DNA next generation sequencing Sponsors: Hunan Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer
Conditions: Prostate Cancer; PET/CT; Survivorship; PSMA Sponsors: University Hospital, Essen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials